Publications
- Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma2018 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphoma2018 | Third Faculty of Medicine
- The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma2017 | First Faculty of Medicine, Third Faculty of Medicine
- The importance of MicroRNA deregulation in the molecular pathogenesis and histological transformation of follicular lymphoma2017 | First Faculty of Medicine, Third Faculty of Medicine
- Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group2016 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The use of formalin-fixed, paraffin-embedded lymph node samples for the detection of minimal residual disease in mantle cell lymphoma2015 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Treatment and Prognosis of Relapsed or Refractory Hodgkin Lymphoma Patients Ineligible for Stem Cell Transplantation2014 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network2013 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma2013 | Second Faculty of Medicine, Third Faculty of Medicine
- Primary central nervous system lymphoma2013 | Third Faculty of Medicine
Loading network view...